Synthesis and Preclinical Evaluation of (177)Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer

The prostate-specific membrane antigen (PSMA)–targeted radiohybrid (rh) ligand [(177)Lu]Lu-rhPSMA-7.3 has recently been assessed in a pretherapeutic dosimetry study on prostate cancer patients. In comparison to [(177)Lu]Lu-PSMA I&T, application of [(177)Lu]Lu-rhPSMA-7.3 resulted in a significant...

Descripción completa

Detalles Bibliográficos
Autores principales: Wurzer, Alexander, Kunert, Jan-Philip, Fischer, Sebastian, Felber, Veronika, Beck, Roswitha, de Rose, Francesco, D’Alessandria, Calogero, Weber, Wolfgang, Wester, Hans-Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2022
Materias:
Basic Science Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536713/
https://www.ncbi.nlm.nih.gov/pubmed/35086894
http://dx.doi.org/10.2967/jnumed.121.263371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536713/
https://www.ncbi.nlm.nih.gov/pubmed/35086894
http://dx.doi.org/10.2967/jnumed.121.263371

Ejemplares similares